Panadol products to shrink this month ahead of sweeping paracetamol changes to reduce harm in Australia

Smaller Panadol pack sizes will appear on shelves this month, ahead of the new Therapeutic Goods Administration (TGA) rules restricting the quantity of paracetamol sold within a single product.

The new 16-tablet/capsule limit for supermarket and convenience store products does not come into effect until February next year, but Pandadol parent company, Haleon, is getting a head start.

“New Panadol packs are rolling out well in advance to ensure continuity of supply and a smooth transition for retailers and Australians,” it said.

All paracetamol-containing products, such as cold and flu tablets, are affected by the legislated changes, which differ in pharmacies, and when involving a pharmacist.

The TGA change was brought forth last year to reduce harm, after an independent report examined the incidence of serious injury and death from intentional paracetamol overdose.

“(The decision) intends to strike a balance between minimising the incidence and harm from intentional self-poisoning and access to paracetamol for the treatment of acute and chronic pain,” the TGA said.

The amended Poisons Standard reduces the maximum size of packs available for general sale in supermarkets and convenience stores from 20 tablets or capsules to just 16.

That will also be the limit for off-the-shelf sales in pharmacies in Western Australia and Queensland.

In all other states and territories, packs with a maximum of 50 tablets or capsules will be available on pharmacy shelves.

Behind-the-counter sales involving a pharmacist will allow consumers to buy packs with up to 100 tablets or capsules.

In Australia about 225 people are hospitalised, and 50 people die from paracetamol overdose each year, according to the TGA.

Haleon ANZ head of pain Elena Pintado: “Our focus is always on the health of Australians and facilitating responsible self-care.”

“We take our responsibility very seriously to ensure Australians can continue to access Panadol without disruption as these changes come into effect.

“It is important to provide reassurance to Australians that there is no change to the suitability profile and efficacy of paracetamol for pain relief when used as directed.”

If you need help in a crisis, call Lifeline on 13 11 14.

For further information about depression contact beyondblue on 1300224636 or talk to your GP, local health professional or someone you trust.